PARCA (a digital tool) to improve Justice and Health

PARCA(数字工具)改善司法和健康

基本信息

  • 批准号:
    10483296
  • 负责人:
  • 金额:
    $ 25.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-05-01 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Nearly 4.4 million individuals are on community supervision in the United States, with the majority (about 80%) being supervised under probation.1 Justice involved persons (JIPs) have a 474% increased lifetime experience with heroin, a 303% increased use of OxyContin in the last 12 months, and a 256% increased use in pain medication in the last 12 months, compared to the general population.3 One important step in addressing substance use and addiction is getting individuals engaged in the treatment process, as initiation and retention rates are very low for substance use treatment among this population. Q2i successfully developed the Probation/Parole And Reentry Coach Application (PARCA) technology, which includes a Justice Team (JT) Dashboard connected to a mobile app designed for JIPs. The platform enables JIPs to set and manage their personal goals while assisting them in addressing the social determinants of health (SDOH) in order to facilitate and supplement the substance use treatment process. It provides a step-by-step guide and identifies local services and resources that the JIPs can connect with to accomplish these goals. At the same time, it gives the JT a dashboard that enables greater insight on how a JIP is managing their plan. This increased connection and communication between the JT and the JIP is designed to improve the community supervision process. In this Phase 1/Phase 2 Fast Track STTR application, Q2i’s PARCA platform will be refined and implemented in Dallas and Hidalgo Counties to test its efficacy. The primary goal of Phase I is to enhance the PARCA platform for JIP. The study team will accomplish this by recruiting three sets of 2 PPOs/Case Managers willing to use PARCA with five of their clients who have used any opioids in the last 12 months (total JIPs = 30) for 2- weeks. The team will conduct interviews with PPOs and their clients that will inform our user-centered design iterations. Initial interviews will describe barriers and challenges to successful community supervision including accessing MOUD treatment and how PARCA can be improved to address these challenges. Follow- up interviews will describe feasibility (use of the PARCA platform features) and acceptability (engagement with PARCA platform through user engagement logs) of using PARCA platform to locate and access MOUD treatment. The overall goal of Phase II is to test the relative efficacy of supervision as usual (SAU) and PARCA in helping JIPs under community supervision engage in substance use treatment process and reduce subsequent involvement in criminal behavior. Using a stepped wedge effectiveness design, we will evaluate the PARCA platform across probation/parole officers (PPOs) (N=60), probationers/parolees (N=600). PPOs will be randomized in three clusters of 20 people to utilize PARCA. Lastly, we will assess the acceptability and feasibility of PARCA platform by supervision officers and justice-involved persons (JIPs) and whether PARCA improves the working alliance between supervisors and JIPs.
项目概要/摘要 在美国,有近 440 万人接受社区监督,其中大多数(约 80%) 受到缓刑监督。1 司法相关人员 (JIP) 的寿命延长了 474% 吸食海洛因的经验,过去 12 个月内奥施康定的使用量增加了 303%,并且在过去 12 个月内使用量增加了 256% 与一般人群相比,过去 12 个月内服用止痛药的情况。3 解决这一问题的重要一步 物质使用和成瘾使个人参与治疗过程,作为启动和保留 该人群中药物滥用治疗的比率非常低。 Q2i成功开发了 缓刑/假释和重返校园教练应用程序 (PARCA) 技术,其中包括司法团队 (JT) 仪表板连接到专为 JIP 设计的移动应用程序。该平台使 JIP 能够设置和管理他们的 个人目标,同时协助他们解决健康的社会决定因素 (SDOH),以便 促进和补充药物滥用治疗过程。它提供了分步指南并确定 JIP 可以连接本地服务和资源来实现这些目标。同时,它给出 JT 是一个仪表板,可让您更深入地了解 JIP 如何管理其计划。这种增加的连接 JT 和 JIP 之间的沟通旨在改善社区监督流程。在 在这一阶段 1/阶段 2 快速通道 STTR 应用中,Q2i 的 PARCA 平台将在 达拉斯和伊达尔戈县测试其功效。第一阶段的主要目标是增强 PARCA JIP 平台。研究团队将通过招募三组愿意的 PPO/案例经理来实现这一目标 与过去 12 个月内使用过任何阿片类药物的 5 名客户一起使用 PARCA(总 JIP = 30)2- 几周。该团队将与 PPO 及其客户进行访谈,为我们以用户为中心的设计提供信息 迭代。初步访谈将描述成功社区监督的障碍和挑战 包括获得 MOUD 治疗以及如何改进 PARCA 来应对这些挑战。跟随- up 访谈将描述可行性(PARCA 平台功能的使用)和可接受性(参与度) 使用 PARCA 平台(通过用户参与日志)使用 PARCA 平台定位和访问 MOUD 治疗。第二阶段的总体目标是测试照常监管(SAU)和 PARCA 帮助社区监督下的 JIP 参与药物使用治疗过程并减少 随后参与犯罪行为。使用阶梯式楔形有效性设计,我们将评估 PARCA 平台涵盖缓刑/假释官员 (PPO) (N=60)、缓刑犯/假释者 (N=600)。 PPO 将 被随机分为三组,每组 20 人以利用 PARCA。最后,我们将评估可接受性和 监督官员和司法相关人员(JIP)建立 PARCA 平台的可行性以及是否 PARCA 改善了主管和 JIP 之间的工作联盟。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Faye S Taxman其他文献

The cost-effectiveness of implementing in-person and computerized interventions to enhance treatment receipt among drug-involved probationers in two US jurisdictions (Economics of SBI Symposium)
  • DOI:
    10.1186/1940-0640-10-s2-o13
  • 发表时间:
    2015-09-24
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Alexander Cowell;Gary A Zarkin;Brendan Wedehase;Scott T Walters;Faye S Taxman
  • 通讯作者:
    Faye S Taxman
Feasibility of a pretrial diversion pilot in Kent County, Rhode Island
  • DOI:
    10.1186/1940-0640-10-s1-a68
  • 发表时间:
    2015-02-20
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Anna F Tomasulo;Nickolas Zaller;Bradley W Brockmann;Jennifer Lerch;Scott T Walters;Faye S Taxman
  • 通讯作者:
    Faye S Taxman
Client involvement in motivational interviewing sessions targeting substance abuse treatment in the criminal justice system
  • DOI:
    10.1186/1940-0640-10-s1-a67
  • 发表时间:
    2015-02-20
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Teneshia Thurman;Faye S Taxman;Scott T Walters
  • 通讯作者:
    Scott T Walters
Geographic accessibility to addiction, mental health, and HIV/AIDS health-care services for opioid-dependent clients
  • DOI:
    10.1186/1940-0640-10-s1-a10
  • 发表时间:
    2015-02-20
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Curtis J Denton;Debarchana Ghosh;Faye S Taxman;Frederick L Altice
  • 通讯作者:
    Frederick L Altice
Client involvement in a web-based intervention targeting substance abuse treatment in the criminal justice system
  • DOI:
    10.1186/1940-0640-10-s1-a61
  • 发表时间:
    2015-02-20
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Stephanie Spohr;Mayra Rodriguez;Jennifer Lerch;Faye S Taxman;Scott T Walters
  • 通讯作者:
    Scott T Walters

Faye S Taxman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Faye S Taxman', 18)}}的其他基金

HEAL Accelerator: Leveraging Partnerships and Targeted Dissemination to Advance Uptake
HEAL 加速器:利用合作伙伴关系和有针对性的传播来促进吸收
  • 批准号:
    10667038
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
HEAL Accelerator: Leveraging Partnerships and Targeted Dissemination to Advance Uptake
HEAL 加速器:利用合作伙伴关系和有针对性的传播来促进吸收
  • 批准号:
    10915749
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
Implementation and Translation Research Project Core
实施和翻译研究项目核心
  • 批准号:
    10219226
  • 财政年份:
    2019
  • 资助金额:
    $ 25.6万
  • 项目类别:
Implementation and Translation Research Project Core
实施和翻译研究项目核心
  • 批准号:
    10696068
  • 财政年份:
    2019
  • 资助金额:
    $ 25.6万
  • 项目类别:
Admin - Core
管理员 - 核心
  • 批准号:
    10219223
  • 财政年份:
    2019
  • 资助金额:
    $ 25.6万
  • 项目类别:
In-person vs. Computer Interventions to Increase Probation Compliance
面对面与计算机干预以提高缓刑合规性
  • 批准号:
    8607919
  • 财政年份:
    2011
  • 资助金额:
    $ 25.6万
  • 项目类别:
In-person vs. Computer Interventions to Increase Probation Compliance
面对面与计算机干预以提高缓刑合规性
  • 批准号:
    8665758
  • 财政年份:
    2011
  • 资助金额:
    $ 25.6万
  • 项目类别:
In-person vs. Computer Interventions to Increase Probation Compliance
面对面与计算机干预以提高缓刑合规性
  • 批准号:
    8236911
  • 财政年份:
    2011
  • 资助金额:
    $ 25.6万
  • 项目类别:
In-person vs. Computer Interventions to Increase Probation Compliance
面对面与计算机干预以提高缓刑合规性
  • 批准号:
    8661519
  • 财政年份:
    2011
  • 资助金额:
    $ 25.6万
  • 项目类别:
In-person vs. Computer Interventions to Increase Probation Compliance
面对面与计算机干预以提高缓刑合规性
  • 批准号:
    8304729
  • 财政年份:
    2011
  • 资助金额:
    $ 25.6万
  • 项目类别:

相似海外基金

Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
  • 批准号:
    10641500
  • 财政年份:
    2023
  • 资助金额:
    $ 25.6万
  • 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
  • 批准号:
    10485593
  • 财政年份:
    2023
  • 资助金额:
    $ 25.6万
  • 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
  • 批准号:
    10728526
  • 财政年份:
    2023
  • 资助金额:
    $ 25.6万
  • 项目类别:
Development of LPA5 Antagonists as Analgesics
LPA5 拮抗剂镇痛药的开发
  • 批准号:
    10638278
  • 财政年份:
    2023
  • 资助金额:
    $ 25.6万
  • 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
  • 批准号:
    10621646
  • 财政年份:
    2023
  • 资助金额:
    $ 25.6万
  • 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
  • 批准号:
    10425794
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
  • 批准号:
    22K19602
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
  • 批准号:
    10512672
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
  • 批准号:
    10721752
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
  • 批准号:
    10821681
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了